Corcept Therapeutics
CORT
#2417
Rank
A$9.34 B
Marketcap
$88.55
Share price
2.11%
Change (1 day)
142.51%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of December 2024 : A$0.60 Billion

According to Corcept Therapeutics 's latest financial reports the company has A$0.60 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.61 B14.03%
2023-12-31A$0.54 B-14.8%
2022-12-31A$0.63 B105.73%
2021-12-31A$0.30 B-46.2%
2020-12-31A$0.57 B45.41%
2019-12-31A$0.39 B34.3%
2018-12-31A$0.29 B158.19%
2017-12-31A$0.11 B58.99%
2016-12-31A$71.49 M28.81%
2015-12-31A$55.5 M87.34%
2014-12-31A$29.62 M-51.84%
2013-12-31A$61.52 M-31.28%
2012-12-31A$89.52 M131.59%
2011-12-31A$38.65 M59.76%
2010-12-31A$24.19 M-8.93%
2009-12-31A$26.56 M2.38%
2008-12-31A$25.95 M30.65%
2007-12-31A$19.86 M65.59%
2006-12-31A$11.99 M-69.82%
2005-12-31A$39.74 M-17.77%
2004-12-31A$48.33 M210.3%
2003-12-31A$15.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$38.76 B 6,297.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.16 B 2,732.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.10 B 3,382.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$5.41 B 793.01%๐Ÿ‡บ๐Ÿ‡ธ USA
A$32.37 B 5,241.82%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.64 B 3,471.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.22 B-62.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.31 B-48.54%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.79 B 196.79%๐Ÿ‡บ๐Ÿ‡ธ USA